Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Muhammad Morshed"'
Autor:
Christy Wilson, Salima Gasmi, Annie-Claude Bourgeois, Jacqueline Badcock, Navdeep Chahil, Manisha Kulkarni, Min-Kuang Lee, Robbin Lindsay, Patrick Leighton, Muhammad Morshed, Christa Smolarchuk, Jules Koffi
Publikováno v:
Canada Communicable Disease Report. 48:208-218
Autor:
Christy Wilson, Salima Gasmi, Annie-Claude Bourgeois, Jacqueline Badcock, Navdeep Chahil, Manisha Kulkarni, Min-Kuang Lee, Robbin Lindsay, Patrick Leighton, Muhammad Morshed, Christa Smolarchuk, Jules Koffi
Publikováno v:
Relevé des maladies transmissibles au Canada. 48:233-244
Publikováno v:
The Journal of Infection in Developing Countries. 15:1364-1375
Clostridioides difficile can cause colitis and is associated with hospital acquired infections. The C. difficile infection (CDI) is due to production of toxins A and B which bind to epithelial cell surface receptors and triggers signaling pathways, l
Autor:
Carmen L. Charlton, Jonathan B. Gubbay, Amanda Lang, Heidi Wood, Paul Levett, Jamil N. Kanji, Antonia Dibernardo, Jason Robinson, L. Robbin Lindsay, Derek R. Stein, Inna Sekirov, Muhammad Morshed, Todd Hatchette, Michael A. Drebot, Nadia El-Gabalawy, Christian Therrien, Lei Jiao, Vanessa Tran, Julianne V. Kus, Carla Osiowy, Jessica D. Forbes
Publikováno v:
Canada Communicable Disease Report, Vol 47, Iss 4, Pp 171-183 (2021)
Can Commun Dis Rep
Can Commun Dis Rep
The landscape of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnostic testing is rapidly evolving. While serology testing has limited diagnostic capacity for acute infection, its role in providing population-based information on po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03c0ed372b83dd5e035eec16663406b9
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-4-april-2021/laboratory-guidance-sars-cov-2-testing.html
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-4-april-2021/laboratory-guidance-sars-cov-2-testing.html
Autor:
Marion Ripoche, Kateryn Rochon, L. Robbin Lindsay, Erin Fraser, Emily J. Jenkins, Katie M. Clow, Roman McKay, Shaun J. Dergousoff, Douglas Munn, Manisha A. Kulkarni, Curtis Russell, Greg J. German, Genevieve Lumsden, Maarten Voordouw, Claire M. Jardine, Antonia Dibernardo, Michelle D. Evason, Muhammad Morshed, Douglas T Howse, Karine Thivierge, Catherine Bouchard, Joe Nocera, Andreea Slatculescu, Salima Gasmi, Jules K. Koffi, Jackie Badcock, Jennifer Cram, Eleni Galanis, Benoit Talbot, Patrick A. Leighton, Mark P. Nelder, Camille Guillot
Publikováno v:
Relevé des maladies transmissibles au Canada. 46:399-407
Autor:
Jordan M. Sang, Jason Wong, Venessa Ryan, Emma Cumming, Lu Wang, Zishan Cui, Nicanor Bacani, Devon Haag, Nathan J. Lachowsky, Joseph Cox, Daniel Grace, Michael Otterstatter, Muhammad Morshed, Joshua Edward, Troy Grennan, Jillian Arkles, Bobbi Brownrigg, Robert S. Hogg, David M. Moore
Publikováno v:
Canadian journal of public health = Revue canadienne de sante publique.
Syphilis rates have increased in BC and disproportionately affect gay, bisexual, and other men who have sex with men (gbMSM). A social marketing campaign (Syphistory) ran from January to September 2017 with the primary goal of increasing syphilis kno
Autor:
Julianne V. Kus, Carla Osiowy, Richard Garceau, Muhammad Morshed, Guillaume Desnoyers, Michael A. Drebot, Jonathan B. Gubbay, L. Robbin Lindsay, Michel Roger, Carmen L. Charlton, Bouchra Serhir, Denise Fudge, Ihssan Bouhtiauy, Vandana Mohan, Paul N. Levett, Vanessa Tran, Antonia Dibernardo, Nadia El-Gabalawy, Christian Therrien, George Zahariadis, Lei Jiao, Ainsley Gretchen, Robert Needle, Laura Gilbert, Derek R. Stein, Graham Tipples, Jamil N. Kanji, Inna Sekirov, Amanda Lang, Laurel Thorlacius, Jean Longtin
Publikováno v:
Diagnostic Microbiology and Infectious Disease
The COVID-19 pandemic has led to the influx of immunoassays for the detection of antibodies towards severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into the global market. The Canadian Public Health Laboratory Network Serology Task Force
Publikováno v:
Canadian Medical Association Journal. 190:E1478-E1480
KEY POINTS A 68-year-old woman presented to the emergency department in Kelowna, British Columbia, with a 3-day history of fever, fatigue, weakness, confusion, headache and diplopia. On initial assessment, she was febrile (38.8°C), and a screening n
Autor:
Carmen L. Charlton, Vanessa Tran, Muhammad Morshed, Jessica D. Forbes, Nadia El-Gabalawy, Jonathan B. Gubbay, Michael Drebot, Derek R. Stein, Jason Robinson, Carla Osiowy, Jamil Kanj, Todd Hatchette, Paul N. Levett, Lei Jiao, Heidi Wood, Antonia Dibernardo, Inna Sekirov, Julianne V. Kus, Christian Therrien, Amanda Lang, L. Robbin Lindsay
Publikováno v:
Canada Communicable Disease Report, Vol 47, Iss 4, Pp 187-100 (2021)
Le répertoire des tests de diagnostic disponibles du coronavirus du syndrome respiratoire aigu sévère 2 (SRAS-CoV-2) évolue rapidement. Bien que les tests sérologiques aient une capacité de diagnostic limitée concernant l’infection aiguë, l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0c4b0c067006b58126f37678a0a6b9c
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-4-avril-2021/guide-laboratoires-depistage-sras-cov-2.html
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-4-avril-2021/guide-laboratoires-depistage-sras-cov-2.html
Autor:
Heather Ward, Wendy Wobeser, Ian Kitai, Duncan Webster, Muhammad Morshed, Drs Michael Gardam, Madhukar Pai, Dick Menzies, Dennis Kunimoto
Publikováno v:
Canada Communicable Disease Report. 36:1-22
Until recently, the diagnosis of tuberculosis infection depended solely on the tuberculin skin test (TST), an imperfect test with known limitations. The most significant advance in recent times has been the development of T-cell-based interferon-gamm